Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide.

Am J Cardiovasc Drugs · 2026 · PMC12779708 · PMID 40889093

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In patients with stroke/TIA, colchicine treatment resulted in a trend of lower MACE, although this did not reach statistical significance (OR 0.90; 95% CI 0.77–1.05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.